These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16563970)

  • 21. Cost-effectiveness of activated protein C in real-life clinical practice.
    Dhainaut JF; Payet S; Vallet B; França LR; Annane D; Bollaert PE; Le Tulzo Y; Runge I; Malledant Y; Guidet B; Le Lay K; Launois R;
    Crit Care; 2007; 11(5):R99. PubMed ID: 17822547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
    Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure.
    Hutchinson J; Scott DA; Clegg AJ; Loveman E; Royle P; Bryant J; Colquitt JL
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):175-85. PubMed ID: 18248272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
    Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
    Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada.
    Wagner M; Goetghebeur M; Merikle E; Pandya A; Chu P; Taylor DC
    Can J Clin Pharmacol; 2009; 16(2):e331-45. PubMed ID: 19531812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global cost-effectiveness of cataract surgery.
    Lansingh VC; Carter MJ; Martens M
    Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care.
    Smith MY; Cromwell J; DePue J; Spring B; Redd W; Unrod M
    Manag Care; 2007 Jul; 16(7):48-55. PubMed ID: 17907712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of aortic valve replacement in the elderly: an introductory study.
    Wu Y; Jin R; Gao G; Grunkemeier GL; Starr A
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):608-13. PubMed ID: 17320552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cost/benefit relations in heart transplantation].
    Scheld HH; Deng MC; Hammel D; Roeder N; Roetker J
    Z Kardiol; 1994; 83 Suppl 6():139-49. PubMed ID: 7863686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH;
    Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of medical spending in the United States, 1960-2000.
    Cutler DM; Rosen AB; Vijan S
    N Engl J Med; 2006 Aug; 355(9):920-7. PubMed ID: 16943404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing.
    Mahle WT; Vincent RN; Kanter KR
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):542-6. PubMed ID: 16077425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital costs and quality of life during 4 years after very preterm birth.
    Korvenranta E; Linna M; Rautava L; Andersson S; Gissler M; Hallman M; Häkkinen U; Leipälä J; Peltola M; Tammela O; Lehtonen L;
    Arch Pediatr Adolesc Med; 2010 Jul; 164(7):657-63. PubMed ID: 20603467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and cost-effectiveness of allogeneic stem cell transplantation in children are predictable.
    Matthes-Martin S; Pötschger U; Barr R; Martin M; Boztug H; Klingebiel T; Attarbaschi A; Eibler W; Mann G
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1533-9. PubMed ID: 22484665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.
    Alba AC; Alba LF; Delgado DH; Rao V; Ross HJ; Goeree R
    Circulation; 2013 Jun; 127(24):2424-35. PubMed ID: 23697907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Political and economic aspects of heart transplantation].
    Carrel T; Tschanz HU; Mohacsi P
    Schweiz Med Wochenschr; 1998 Aug; 128(35):1298-304. PubMed ID: 9782550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable ventricular assist devices: is it time to introduce them in Canada?
    McGregor M
    Can J Cardiol; 2000 May; 16(5):629-40. PubMed ID: 10833542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost utility evaluation of extracorporeal membrane oxygenation as a bridge to transplant for children with end-stage heart failure due to dilated cardiomyopathy.
    Brown KL; Wray J; Wood TL; Mc Mahon AM; Burch M; Cairns J
    J Heart Lung Transplant; 2009 Jan; 28(1):32-8. PubMed ID: 19134528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.